DELRAY BEACH, Fla., Jan. 23, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the RFID Market is expected to grow from ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

Global Health Data Archiving Market size is expected to be worth around USD 3.4 Billion by 2033 from USD 1.4 Billion in 2023 ...

Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is initiating a strategic collaboration with NorthX Biologics to further develop and scale ...

Researchers at the University of Oulu, Finland, have developed a pine‑bark–based water‑treatment medium that efficiently ...

Research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome operational ...

The global simulation market is poised for robust growth, driven by AI-powered modeling, immersive VR training, and ...

Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...

Monthly real GDP is estimated to have grown by 0.3% in November 2025, following an unrevised fall of 0.1% in October 2025. Services and production both grew in November 2025, by 0.3% and 1.1%, ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.